PDCD1 and non-small cell lung carcinoma: To determine the impact of SIRPG expression on clinical outcomes in patients treated with PD-1 blockade monotherapy, we conducted an integrated analyses of the transcriptomic and treatment outcome data of patients with advanced NSCLC receiving PD-1 blockade monotherapy.